Repository logo
 

Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.

Accepted version
Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/285473

Repository DOI

https://doi.org/10.17863/CAM.32831
No Thumbnail Available

Files

Accepted version (59.5 KB)

Type

Article

Change log

Authors

Saarela, Mika 
Senthil, Keerthi 
Jones, Joanne 
Tienari, Pentti J 
Soilu-Hänninen, Merja 
Show 3 more

Description

Keywords

Adult, Alemtuzumab, Fatal Outcome, Female, Humans, Immunologic Factors, Lymphohistiocytosis, Hemophagocytic, Male, Multiple Sclerosis, Relapsing-Remitting

Journal Title

Neurology

Conference Name

Journal ISSN

0028-3878
1526-632X

Volume Title

90

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publisher DOI

https://doi.org/10.1212/WNL.0000000000005420

Rights

http://www.rioxx.net/licenses/all-rights-reserved
Sponsorship
Wellcome Trust (105924/Z/14/Z)
Wellcome Trust (105924/Z/14/A)
Wellcome Trust (105924/Z/14/Z)
Wellcome Trust (105924/Z/14/A)
Medical Research Council (G1100114)

Collections

Cambridge University Research Outputs